rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Joerg Neermann

Director

Company insider

Files Form 4 as: Director, Immunic.

In numbers

Trades disclosed
21
Buys
5
Sells
0
Bought
$205K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
22 Jul 2019
Last trade
5 Jul 2026
Last filed
7 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
IMUX ImmunicDirector · Biotechnology · last 5 Jul 20265 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
02Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
5 Jul 2026filed 7 Jul 2026IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code A—25,370 at $0.00filing
5 Jul 2026filed 7 Jul 2026IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code A—25,370 at $0.00filing
29 Jun 2026filed 29 Jun 2026IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code A—25,370 at $0.00filing
29 Jun 2026filed 29 Jun 2026IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code A—25,370 at $0.00filing
5 Jun 2025filed 9 Jun 2025IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code A—150,000 at $0.00filing
5 Jun 2025filed 5 Jun 2025IMUX ImmunicBiotechnologySEC FORM 4 Bought$23K30,000 at $0.76filing
4 Jun 2025filed 5 Jun 2025IMUX ImmunicBiotechnologySEC FORM 4 Bought$54K70,000 at $0.77filing
11 Jun 2024filed 12 Jun 2024IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing
4 Mar 2024filed 6 Mar 2024IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code D—29,959filing
4 Mar 2024filed 6 Mar 2024IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code D—15,000filing
4 Mar 2024filed 6 Mar 2024IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code D—10,000filing
4 Mar 2024filed 6 Mar 2024IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code D—10,000filing
4 Mar 2024filed 6 Mar 2024IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code A—64,959filing
28 Jun 2023filed 29 Jun 2023IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code A—16,000 at $0.00filing
14 Dec 2022filed 15 Dec 2022IMUX ImmunicBiotechnologySEC FORM 4 Bought$59K47,000 at $1.26filing
13 Dec 2022filed 15 Dec 2022IMUX ImmunicBiotechnologySEC FORM 4 Bought$44K35,000 at $1.25filing
23 Nov 2022filed 25 Nov 2022IMUX ImmunicBiotechnologySEC FORM 4 Bought$25K18,000 at $1.39filing
15 Jun 2022filed 17 Jun 2022IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
10 Jun 2021filed 14 Jun 2021IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
2 Jul 2020filed 6 Jul 2020IMUX Immunicoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care5

Buys in green, sells in red, by the company’s sector.

Related people

BVF PARTNERS L P/ILDirector and Other role · Director and Other at Immunic, filing Form 4 there in the last year
Robert Thorvald NagelDirector · Director at Immunic, filing Form 4 there in the last year
Elena RidloffCFO and CBO · Director at Immunic, filing Form 4 there in the last year
Simona SkerjanecDirector · Director at Immunic, filing Form 4 there in the last year
Jon CongletonChief Executive Officer · Director at Immunic, filing Form 4 there in the last year